Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
Discoidin domain receptor 1 (DDR1) kinase has emerged as a promising target for cancer therapy, and selective DDR1 inhibitors have shown promise as effective therapeutic candidates. Herein, we have identified the first coumarin-based selective DDR1 inhibitors via repurposing of a recent series of ca...
Saved in:
Main Authors: | Ashraf K. El-Damasy (Author), Hyun Ji Kim (Author), Ahmed A. Al-Karmalawy (Author), Radwan Alnajjar (Author), Mohamed M. Khalifa (Author), Eun-Kyoung Bang (Author), Gyochang Keum (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis
by: Xiaoli Li, et al.
Published: (2022) -
Discoidin Domain Receptors: Potential Actors and Targets in Cancer
by: Hassan eRammal, et al.
Published: (2016) -
The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2
by: Ria Aryani Hayuningtyas, et al.
Published: (2021) -
Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant
by: Ashraf K. El-Damasy, et al.
Published: (2023) -
An expression of concern on Discoidin Domain Receptors: Potential Actors and Targets in Cancer
by: Frontiers Editorial Office
Published: (2016)